BIOGEN INC. Payments to Acquire in Process Research and Development
BIOGEN INC. (BIIB) reported Payments to Acquire in Process Research and Development of $35.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment · last filed 2026-04-29
- BIOGEN INC. payments to acquire in process research and development for the quarter ending 2026-03-31 was $35.00M.
- BIOGEN INC. payments to acquire in process research and development for the quarter ending 2025-03-31 was $0.00.
- BIOGEN INC. payments to acquire in process research and development for the quarter ending 2022-12-31 was $0.00.
- BIOGEN INC. payments to acquire in process research and development for the quarter ending 2021-12-31 was $0.00.
- BIOGEN INC. payments to acquire in process research and development for fiscal 2025 was $50.00M.
- BIOGEN INC. payments to acquire in process research and development for fiscal 2024 was $0.00.
- BIOGEN INC. payments to acquire in process research and development for fiscal 2023 was $0.00.
- BIOGEN INC. payments to acquire in process research and development for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments to Acquire in Process Research and Development 3 month | Payments to Acquire in Process Research and Development 6 month | Payments to Acquire in Process Research and Development 9 month | Payments to Acquire in Process Research and Development 12 month |
|---|---|---|---|---|
| 2026-03-31 | $35.00M 10-Q · filed 2026-04-29 | |||
| 2025-12-31 | $50.00M 10-K · filed 2026-02-06 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-04-29 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-02-06 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-06 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $0.00 10-K · filed 2023-02-15 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-10-25 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $18.00M derived: sum of 2 quarters · filed 2024-02-14 | $18.00M derived: sum of 3 quarters · filed 2024-02-14 | $18.00M 10-K · filed 2024-02-14 |
| 2021-09-30 | $18.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $18.00M derived: sum of 2 quarters · filed 2022-10-25 | $18.00M 10-Q · filed 2022-10-25 | $18.00M derived: sum of 4 quarters · filed 2023-02-15 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | $0.00 10-Q · filed 2021-07-22 | $0.00 derived: sum of 3 quarters · filed 2023-02-15 | $0.00 derived: sum of 4 quarters · filed 2023-02-15 |
| 2021-03-31 | $0.00 10-Q · filed 2021-04-22 | $0.00 derived: sum of 2 quarters · filed 2023-02-15 | $0.00 derived: sum of 3 quarters · filed 2023-02-15 | $0.00 derived: sum of 4 quarters · filed 2023-02-15 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $0.00 derived: sum of 2 quarters · filed 2023-02-15 | $0.00 derived: sum of 3 quarters · filed 2023-02-15 | $75.00M 10-K · filed 2023-02-15 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $0.00 derived: sum of 2 quarters · filed 2021-10-20 | $75.00M 10-Q · filed 2021-10-20 | $75.00M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | $75.00M 10-Q · filed 2021-07-22 | $75.00M derived: sum of 3 quarters · filed 2022-02-03 | $75.00M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-03-31 | $75.00M 10-Q · filed 2021-04-22 | $75.00M derived: sum of 2 quarters · filed 2022-02-03 | $75.00M derived: sum of 3 quarters · filed 2022-02-03 | $75.00M derived: sum of 4 quarters · filed 2022-02-03 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $0.00 derived: sum of 2 quarters · filed 2022-02-03 | $0.00 derived: sum of 3 quarters · filed 2022-02-03 | $0.00 10-K · filed 2022-02-03 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-21 | $0.00 derived: sum of 2 quarters · filed 2020-10-21 | $0.00 10-Q · filed 2020-10-21 | $0.00 derived: sum of 4 quarters · filed 2021-02-03 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | $0.00 10-Q · filed 2020-07-22 | $0.00 derived: sum of 3 quarters · filed 2021-02-03 | $27.50M derived: sum of 4 quarters · filed 2021-02-03 |
| 2019-03-31 | $0.00 10-Q · filed 2020-04-23 | $0.00 derived: sum of 2 quarters · filed 2021-02-03 | $27.50M derived: sum of 3 quarters · filed 2021-02-03 | $102.50M derived: sum of 4 quarters · filed 2021-02-03 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $27.50M derived: sum of 2 quarters · filed 2021-02-03 | $102.50M derived: sum of 3 quarters · filed 2021-02-03 | $112.50M 10-K · filed 2021-02-03 |
| 2018-09-30 | $27.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | $102.50M derived: sum of 2 quarters · filed 2019-10-22 | $112.50M 10-Q · filed 2019-10-22 | $112.50M derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-06-30 | $75.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $85.00M 10-Q · filed 2019-07-24 | $85.00M derived: sum of 3 quarters · filed 2020-02-06 | $85.00M derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-03-31 | $10.00M 10-Q · filed 2019-04-24 | $10.00M derived: sum of 2 quarters · filed 2020-02-06 | $10.00M derived: sum of 3 quarters · filed 2020-02-06 | $130.00M derived: sum of 4 quarters · filed 2020-02-06 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $0.00 derived: sum of 2 quarters · filed 2020-02-06 | $120.00M derived: sum of 3 quarters · filed 2020-02-06 | $120.00M 10-K · filed 2020-02-06 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | $120.00M derived: sum of 2 quarters · filed 2018-10-23 | $120.00M 10-Q · filed 2018-10-23 | $120.00M derived: sum of 4 quarters · filed 2019-02-06 |
| 2017-06-30 | $120.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-24 | $120.00M 10-Q · filed 2018-07-24 | $120.00M derived: sum of 3 quarters · filed 2019-02-06 | $120.00M derived: sum of 4 quarters · filed 2019-02-06 |
| 2017-03-31 | $0.00 10-Q · filed 2018-04-24 | $0.00 derived: sum of 2 quarters · filed 2019-02-06 | $0.00 derived: sum of 3 quarters · filed 2019-02-06 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $0.00 derived: sum of 2 quarters · filed 2019-02-06 | $0.00 10-K · filed 2019-02-06 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | $0.00 10-Q · filed 2017-10-24 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-07-25 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-02-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |